Profound Medical

Profound Medical

Yahoo Finance • 3 days ago

3 Canadian AI Healthcare Stocks With Revenue Growth Up To 53%

AI data centres are drawing huge new power infrastructure in places like Teesside, and that demand for computing muscle has a direct read across to Canadian healthcare companies building AI tools for hospitals, clinics, and research labs.... Full story

Yahoo Finance • 6 days ago

Profound Medical and Cook Medical’s iMRI Division Partner to Expand U.S. TULSA-PRO® Sales Channels and Drive Recurring Revenue Growth

Profound Medical Corp. New distribution agreement positions TULSA-PRO within the iMRI Suite offering through Cook Medical's Copernicus™ program, expanding Profound's commercial reach Profound retains direct TULSA-PRO recurring treatment... Full story

Yahoo Finance • 22 days ago

TULSA Abstracts at the 15th Interventional MRI Symposium Strengthen Real-World Evidence, Clinical Differentiation, and Platform Expansion Opportunity

Profound Medical Corp. TORONTO, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company") today announced that five abstracts presented at the 15th Interventional MRI ("iMRI") Symposium... Full story

Yahoo Finance • last month

3 Canadian AI Healthcare Stocks With Market Caps Up To $296 Million

Global debt costs are climbing, with interest bills now larger than many governments spend on AI itself. That squeeze on public budgets is pushing attention toward private companies building real AI tools that healthcare providers can pay... Full story

Yahoo Finance • 3 months ago

Sector Update: Healthcare Stocks Higher Late Afternoon

Healthcare stocks rose late Friday afternoon, with the NYSE Healthcare Index up 0.6% and the State S PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 4 months ago

Profound Medical Corp. (PROF) Dropped Despite High Potential

Grow Funds, an investment Advisor, released its Q1 2026 investor letter for "GROW Small Cap Equity Long/Short Fund". A copy of the letter can be downloaded here. In Q1 2026, GROW Small Cap Equity Long/Short L.P (Fund) returned 4.18%, outpe... Full story

Yahoo Finance • 7 months ago

Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference

TORONTO, April 14, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies... Full story

Yahoo Finance • 7 months ago

Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone

TORONTO, March 27, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies... Full story

Yahoo Finance • 8 months ago

Profound Medical outlines path to $85M revenue and profitable growth with TULSA expansion in 2026

Earnings Call Insights: Profound Medical Corp. (PRN:CA) Q4 2025 MANAGEMENT VIEW * Arun Menawat, Chairman & CEO, emphasized the completion of recruitment for CAPTAIN, the first multicenter, randomized, controlled trial comparing a new t... Full story

Yahoo Finance • 10 months ago

Profound Medical Corp. Announces Closing of Private Placement

TORONTO, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that it has completed its previously announced private placement of common shares to Canadian i... Full story

Yahoo Finance • 10 months ago

Profound Medical increases private placement to $6.45M

* Profound Medical (NASDAQ: PROF [https://seekingalpha.com/symbol/PROF]) on Wednesday had increased its December 19, 2025, private placement to allow participation by a long-term existing investor, with gross proceeds of up to $6.45M fro... Full story

Yahoo Finance • 11 months ago

Stanford Medicine’s Dr. Pejman Ghanouni Receives RSNA’s Cum Laude Award for CAPTAIN Perioperative Data Presentation

TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies f... Full story

Yahoo Finance • 11 months ago

Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings

TORONTO, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies f... Full story

Yahoo Finance • 12 months ago

Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease

TORONTO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies f... Full story

Yahoo Finance • 12 months ago

Profound Medical Reports Strong Third Quarter 2025 Financial Results

TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies f... Full story

Yahoo Finance • 12 months ago

شركة Profound Medical توقع اتفاقية توزيع حصرية لمنتجات TULSA-PRO®وSonalleve® مع شركة Al Faisaliah Medical Systems في المملكة العربية السعودية

الاتفاقية تفتح المجال أمام علاجات Profound التي لا تستلزم أي جراحة أو إشعاع لاستئصال الأنسجة المريضة، لتخترق بذلك أكبر سوق للرعاية الصحية في الشرق الأوسط تم الحصول بالفعل على جميع الموافقات التنظيمية اللازمة لاستيراد وبيع تقنيتي الاستئصال... Full story

Yahoo Finance • 12 months ago

Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO® to Australia and New Zealand

TORONTO, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies f... Full story

Yahoo Finance • 12 months ago

Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO® in Canada from Knight

TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets artificial intelligence (“AI”)-powered, MRI-guide... Full story

Yahoo Finance • last year

Profound Medical to Participate in the Stifel 2025 Healthcare Conference

TORONTO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies... Full story

Yahoo Finance • last year

Profound Medical achieves record prelim revenue for third quarter

* Profound Medical (NASDAQ:PROF [https://seekingalpha.com/symbol/PROF]) announced [https://seekingalpha.com/pr/20256714-profound-medical-achieves-record-preliminary-unaudited-revenue-for-the-2025-third-quarter] on Tuesday preliminary una... Full story